IKNA Stock: Ikena Oncology, Inc. Stock Price, Analysis & Insights

Get live IKNA stock price $17.16, comprehensive Ikena Oncology, Inc. stock analysis, charts, news, and expert forecast. Real-time IKNA stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

17.16

1,152.55%Today

IKNA • Ikena Oncology, Inc. • NASDAQ Global Market • Healthcare

Market Cap

718.82M

Volume

457.26K

52W High

23.28

52W Low

1.36

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Ikena Oncology, Inc. is a biopharmaceutical company specializing in precision oncology. Its primary objective is to create therapeutic agents specifically formulated for patient populations identified through biomarkers, thereby addressing significan...

Contact Information

Website: https://ikenaoncology.com
Address: 645 Summer Street
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: 0.50) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Ikena Oncology, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Ikena Oncology, Inc.
⚠Investors should consider how Ikena Oncology, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

718.82M

P/E Ratio (TTM)

-2.23

Beta

0.50

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare IKNA with peer companies:

ASLAN Pharmaceuticals Limited (ASLN)

Price: $0.60
Market cap: 194.28M

Avid Bioservices, Inc. (CDMO)

Price: $12.49
Market cap: 798.90M

Chimerix, Inc. (CMRX)

Price: $8.54
Market cap: 801.08M

Exscientia plc (EXAI)

Price: $4.84
Market cap: 633.18M

Intercept Pharmaceuticals, Inc. (ICPT)

Price: $19.00
Market cap: 794.69M

Icosavax, Inc. (ICVX)

Price: $15.31
Market cap: 769.04M

iTeos Therapeutics, Inc. (ITOS)

Price: $10.15
Market cap: 448.68M

Invivyd, Inc. (IVVD)

Price: $0.96
Market cap: 127.55M

Niagen Bioscience Inc (NAGE)

Price: $3.51
Market cap: 279.85M

Sage Therapeutics, Inc. (SAGE)

Price: $8.68
Market cap: 544.94M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.